Two years have passed since WHO declared a pandemic state for SARS-CoV-2 infection.
COVID-19 pathogenesis consists of a first viral phase responsible for early symptoms …

Psoriasis is an immune-mediated chronic inflammatory skin disease that affects 2% to 3% of
the world's population. It is widely assumed that immune cells and cytokines acting together …

Psoriasis is an inflammatory skin disease that is intricately linked to oxidative stress.
Antioxidation and inhibition of abnormal proliferation of keratinocytes are pivotal strategies …

Background Obesity and dyslipidemia, major global health concerns, have been linked to
psoriasis, but previous studies faced methodological limitations and their shared genetic …

Psoriasis is a multifactorial disease that affects 0.84% of the global population and it can be
associated with disabling comorbidities. As patients present with thick scaly lesions …

The transcription factor LIM‐only protein 4 (LMO4) is overexpressed in the psoriatic
epidermis and regulates keratinocyte proliferation and differentiation. High LMO4 …

Psoriasis is an erythematous-squamous dermatosis with a polygenic inheritance history.
Both environmental and genetic factors play a role in the etiology of the disease. Over the …

Curcumin (Cur) is an anti-inflammatory polyphenol that can be complexed with polymeric
cyclodextrin (CD) to improve solubility and bioavailability. The aim of the present work was …

Background: Real-world, primary data on the treatment of psoriasis are scarce, especially
concerning the role of soluble biomarkers as outcome predictors. Objective: The authors …

We investigated the whole blood GLUT1 mRNA expression and serum pigment epithelium-
derived factor (PEDF), interleukin-6 (IL-6), fetuin-A, and pentraxin-3 (PTX3) levels in …